Bunge Global Sa (BG)
NYSE:BG
Want to see BG full AI Analyst Report?
Top Page
Bunge Global
(NYSE:BG)
Select Model
Select Model
Rating:63Neutral
Price Target:
$135.00
â–²(13.20% Upside)
Action:ReiteratedDate:04/29/26
The score is held back primarily by mixed financial performance (thinner margins, higher leverage, and uneven cash conversion), while technicals are supportive with the stock above major moving averages. The latest earnings call is a key positive due to the sizable guidance raise and improving leverage, and valuation is reasonable with a moderate dividend yield.
Positive Factors
Improving leverage & ample liquidity
A materially lower adjusted net debt/EBITDA (1.6x) and large committed facilities increase financial flexibility and reduce refinancing risk. This durable improvement supports multi-year capex, M&A integration and working-capital swings common in agribusiness, helping sustain execution through cycles.
Negative Factors
Elevated leverage vs historical levels
Materially higher absolute debt and a higher debt-to-equity profile meaningfully reduce balance-sheet flexibility. Over the medium term this increases sensitivity to higher interest costs, limits optionality for buybacks or aggressive dividend growth, and raises exposure to funding stress during commodity-driven working-capital swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage & ample liquidity
A materially lower adjusted net debt/EBITDA (1.6x) and large committed facilities increase financial flexibility and reduce refinancing risk. This durable improvement supports multi-year capex, M&A integration and working-capital swings common in agribusiness, helping sustain execution through cycles.
Read all positive factors
Bunge Global (BG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$24.65B
Dividend Yield3.14%
Average Volume (3M)1.87M
Price to Earnings (P/E)90.6
Beta (1Y)0.21
Revenue Growth56.89%
EPS Growth-45.77%
CountryUS
Employees34,000
SectorConsumer Defensive
Sector Strength42
IndustryAgricultural Farm Products
Share Statistics
EPS (TTM)1.83
Shares Outstanding194,018,110
10 Day Avg. Volume1,453,359
30 Day Avg. Volume1,870,109
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.85
Price to Sales (P/S)0.21
P/FCF Ratio-15.93
Enterprise Value/Market Cap1.54
Enterprise Value/Revenue0.47
Enterprise Value/Gross Profit9.03
Enterprise Value/Ebitda13.76
Forecast
1Y Price Target
$141.00Price Target Upside18.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)8.81
Revenue Forecast (FY)$91.74B
Bunge Global Business Overview & Revenue Model
Company Description
Bunge Limited operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes,...
How the Company Makes Money
Bunge primarily makes money by buying agricultural commodities (notably oilseeds such as soybeans and other grains), transforming and moving them through its network, and selling processed and merchandised products to end markets. A major revenue ...
Bunge Global Key Performance Indicators (KPIs)
Bunge Global Earnings Call Summary
Earnings Call Date:Apr 29, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 05, 2026
Earnings Call Sentiment Positive
The call conveyed a net positive operating and financial momentum: management raised full-year adjusted EPS guidance materially, reported strong adjusted EBIT growth (+62.8%), showed improving leverage and robust liquidity, and highlighted successful integration and synergy capture from Viterra. Offsetting negatives included a large reduction in reported EPS driven by mark-to-market timing and one-time integration costs, softness in Grain Merchandising & Milling and parts of Tropical Oils, and increased interest and working capital pressure amid macro/geopolitical uncertainty. On balance, the positive operational execution, guidance raise and balance sheet/liquidity strength outweigh the near-term headwinds and timing-related noise.Positive Updates
Raised Full-Year Adjusted EPS Guidance
Full-year 2026 adjusted EPS guidance increased to $9.00–$9.50 from prior $7.50–$8.00 (midpoint up from $7.75 to $9.25, ~+19% at the midpoint), reflecting strong Q1 results and forward curves.
Negative Updates
Reported EPS Decline Due to Timing and Transaction Costs
Reported Q1 EPS was $0.35 vs. $1.48 a year ago (down ~76.4%). The decline was driven by an unfavorable mark-to-market timing difference of $1.28 per share and a $0.20 per share impact related to Viterra transaction and integration costs.
Read all updates
Q1-2026 Updates
Positive
Negative
Raised Full-Year Adjusted EPS Guidance
Full-year 2026 adjusted EPS guidance increased to $9.00–$9.50 from prior $7.50–$8.00 (midpoint up from $7.75 to $9.25, ~+19% at the midpoint), reflecting strong Q1 results and forward curves.
Read all positive updates
Company Guidance
Management raised full‑year adjusted EPS guidance to $9.00–$9.50 (up from $7.50–$8.00) after a strong Q1 (adjusted EPS $1.83; adjusted segment EBIT $661M), and set an expected 2026 cadence of ~40% of earnings in H1 / 60% in H2 (Q3/Q4 ~45%/55%); they now expect an adjusted annual effective tax rate of 22–26% (vs. 23–27%), net interest expense of $620–$660M (vs. $575–$625M), capital expenditures of $1.5–$1.7B and depreciation & amortization of ~ $975M. Liquidity and leverage metrics remain solid: adjusted net debt/EBITDA was 1.6x at quarter end (vs. 1.9x YE2025), readily marketable inventories exceeded net debt by ~ $400M, committed unused credit facilities were ~$9.7B and the $3B commercial paper program was essentially unutilized. Q1 cash flow and capital allocation included adjusted funds from operations of $530M, sustaining CapEx $95M, discretionary cash flow of $435M, $136M of dividends, ~$240M of growth/productivity CapEx, $105M for the IFF soy protein/lecithin acquisition and a net use of $47M; trailing‑12‑month metrics cited adjusted ROIC 8% (9% excluding CIPP/excess cash), ROIC 6.7% (7.2% adjusted), discretionary cash flow ≈ $1.35B and cash return on equity 9.1% vs. a 7.2% cost of equity.Bunge Global Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
55
Neutral
Cash Flow
44
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.54B | 70.33B | 53.11B | 59.54B | 67.23B | 59.15B |
| Gross Profit | 4.20B | 3.17B | 3.39B | 4.84B | 3.68B | 3.36B |
| EBITDA | 2.76B | 1.76B | 2.46B | 4.02B | 2.88B | 3.23B |
| Net Income | 686.00M | 819.00M | 1.14B | 2.24B | 1.61B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 47.58B | 44.53B | 24.90B | 25.37B | 24.58B | 23.82B |
| Cash, Cash Equivalents and Short-Term Investments | 839.00M | 1.34B | 3.79B | 2.71B | 1.22B | 1.42B |
| Total Debt | 14.33B | 16.95B | 7.12B | 5.76B | 5.62B | 6.82B |
| Total Liabilities | 30.10B | 27.11B | 13.95B | 13.56B | 14.62B | 15.61B |
| Stockholders Equity | 17.43B | 17.37B | 9.91B | 10.85B | 9.22B | 7.67B |
Cash Flow | ||||||
| Free Cash Flow | 112.00M | -923.00M | 524.00M | 2.19B | -6.10B | -3.29B |
| Operating Cash Flow | 578.00M | 800.00M | 1.90B | 3.31B | -5.55B | -2.89B |
| Investing Cash Flow | -5.16B | -5.04B | -1.11B | -1.01B | 6.50B | 5.11B |
| Financing Cash Flow | 2.20B | 2.07B | -90.00M | -856.00M | -769.00M | -1.63B |
Bunge Global Technical Analysis
Neutral
119.26
Price Trends
122.08
Negative
110.42
Positive
96.82
Positive
Market Momentum
0.01
Positive
42.17
Neutral
18.80
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BG, the sentiment is Neutral. The current price of 119.26 is below the 20-day moving average (MA) of 124.59, below the 50-day MA of 122.08, and above the 200-day MA of 96.82, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 42.17 is Neutral, neither overbought nor oversold. The STOCH value of 18.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BG.
Bunge Global Risk Analysis
Bunge Global disclosed 29 risk factors in its most recent earnings report. Bunge Global reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Bunge Global Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $3.66B | 20.41 | 26.11% | 10.53% | -8.85% | -29.16% | |
78 Outperform | $10.34B | 10.87 | 15.25% | 4.44% | 8.00% | -1.43% | |
70 Outperform | $1.99B | 18.92 | 4.53% | 3.34% | 1.38% | -36.13% | |
66 Neutral | $35.92B | 25.81 | 4.80% | 3.55% | -6.04% | -38.43% | |
63 Neutral | $24.65B | 90.61 | 4.45% | 3.14% | 56.89% | -45.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $22.11B | 59.42 | 1.10% | 3.48% | 2.83% | -80.89% |
* Consumer Defensive Sector Average
BG
Bunge Global
124.61
49.12
65.07%
ADM
Archer Daniels Midland
74.94
29.06
63.34%
CALM
Cal-Maine Foods
76.25
-11.93
-13.53%
FDP
Fresh Del Monte Produce
41.34
9.00
27.81%
TSN
Tyson Foods
63.68
9.52
17.57%
SFD
Smithfield Foods
26.29
4.65
21.50%
Bunge Global Corporate Events
Financial DisclosuresRegulatory Filings and Compliance
Bunge Global Discloses Direct Financial Obligation in Filing
Neutral
Apr 2, 2026
Bunge Global, a company operating in the agribusiness and food sectors, referenced information previously disclosed in Item 1.01 of its Current Report on Form 8-K as applicable to Item 2.03. This procedural disclosure indicates that details concer...
Business Operations and StrategyExecutive/Board Changes
Bunge Global Launches Executive Incentive Tied to Viterra Integration
Positive
Apr 1, 2026
On March 26, 2026, Bunge Global SA’s board approved a special, one-time Executive Integration Incentive Program granting performance-based restricted stock units to senior officers, including CEO Gregory Heckman and other named executives. T...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Bunge Global Raises $1.2 Billion Through Senior Notes
Positive
Mar 19, 2026
On March 17, 2026, Bunge Limited Finance Corp., a wholly owned subsidiary of Bunge Global SA, completed the sale and issuance of $1.2 billion in senior unsecured notes, split between $500 million of 4.800% notes due 2033 and $700 million of 5.150%...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Bunge Global Completes Acquisition of Viterra Limited
Neutral
Mar 17, 2026
On July 2, 2025, Bunge Global SA completed its previously announced stock-and-cash acquisition of Viterra Limited from a shareholder group that included affiliates of Glencore, Canada Pension Plan Investment Board, and British Columbia Investment ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.